ENTRY       D12724                      Drug
NAME        Forimtamig (USAN/INN)
FORMULA     C8551H13244N2300O2698S58
EXACT_MASS  193175.3647
MOL_WEIGHT  193294.2143
SEQUENCE    (A chain)
            EVQLLESGGG LVQPGGSLRL SCAASGFTFS KYAMAWVRQA PGKGLEWVAS ISTGGVNTYY
            ADSVKGRFTI SRDNSKNTLY LQMNSLRAED TAVYYCATHT GDYFDYWGQG TMVTVSSAST
            KGPSVFPLAP SSKSTSGGTA ALGCLVEDYF PEPVTVSWNS GALTSGVHTF PAVLQSSGLY
            SLSSVVTVPS SSLGTQTYIC NVNHKPSNTK VDEKVEPKSC DGGGGSGGGG SQAVVTQEPS
            LTVSPGGTVT LTCGSSTGAV TTSNYANWVQ EKPGQAFRGL IGGTNKRAPG TPARFSGSLL
            GGKAALTLSG AQPEDEAEYY CALWYSNLWV FGGGTKLTVL SSASTKGPSV FPLAPSSKST
            SGGTAALGCL VKDYFPEPVT VSWNSGALTS GVHTFPAVLQ SSGLYSLSSV VTVPSSSLGT
            QTYICNVNHK PSNTKVDKKV EPKSCDKTHT CPPCPAPEAA GGPSVFLFPP KPKDTLMISR
            TPEVTCVVVD VSHEDPEVKF NWYVDGVEVH NAKTKPREEQ YNSTYRVVSV LTVLHQDWLN
            GKEYKCKVSN KALGAPIEKT ISKAKGQPRE PQVYTLPPCR DELTKNQVSL WCLVKGFYPS
            DIAVEWESNG QPENNYKTTP PVLDSDGSFF 	LYSKLTVDKS RWQQGNVFSC
            SVMHEALHNH YTQKSLSLSP GK
            (B chain)
            EVQLLESGGG LVQPGGSLRL SCAASGFTFS KYAMAWVRQA PGKGLEWVAS ISTGGVNTYY
            ADSVKGRFTI SRDNSKNTLY LQMNSLRAED TAVYYCATHT GDYFDYWGQG TMVTVSSAST
            KGPSVFPLAP SSKSTSGGTA ALGCLVEDYF PEPVTVSWNS GALTSGVHTF PAVLQSSGLY
            SLSSVVTVPS SSLGTQTYIC NVNHKPSNTK VDEKVEPKSC DKTHTCPPCP APEAAGGPSV
            FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVKFNWYVD GVEVHNAKTK PREEQYNSTY
            RVVSVLTVLH QDWLNGKEYK CKVSNKALGA PIEKTISKAK GQPREPQVCT LPPSRDELTK
            NQVSLSCAVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLVSKL TVDKSRWQQG
            NVFSCSVMHE ALHNHYTQKS LSLSPGK
            (C chain)
            EVQLLESGGG LVQPGGSLRL SCAASGFQFS SYAMNWVRQA PGKGLEWVSR IRSKYNNYAT
            YYADSVKGRF TISRDDSKNT LYLQMNSLRA EDTAVYYCVR HTTFPSSYVS YYGYWGQGTL
            VTVSSASVAA PSVFIFPPSD EQLKSGTASV VCLLNNFYPR EAKVQWKVDN ALQSGNSQES
            VTEQDSKDST YSLSSTLTLS KADYEKHKVY ACEVTHQGLS SPVTKSFNRG EC
            (D chain)
            EIVLTQSPGT LSLSPGERAT LSCRASQSVS ISGINLMNWY QQKPGQQPKL LIYHASILAS
            GIPDRFSGSG SGTDFTLTIS RLEPEDFAVY YCQQTRESPL TFGQGTRLEI KRTVAAPSVF
            IFPPSDRKLK SGTASVVCLL NNFYPREAKV QWKVDNALQS GNSQESVTEQ DSKDSTYSLS
            STLTLSKADY EKHKVYACEV THQGLSSPVT KSFNRGEC
            (Disulfide bridge: A22-A96, A144-A200, A220-D218, A253-A321, A369-A425, A445-C232, A451-B226, A454-B229, A486-A546, A579-B34, A592-A650, B22-B96, B144-B200, B220-D'218, B261-B321, B367-B425, C22-C98, C152-C212, D23-D92, D138-D198, D'23-D'92, D'138-D'198)
  TYPE      Peptide
EFFICACY    Antineoplastic
  TYPE      Monoclonal antibody, bispecific antibody
TARGET      GPRC5D [HSA:55507] [KO:K04621]
            CD3E [HSA:916] [KO:K06451]
  PATHWAY   hsa04640(916)  Hematopoietic cell lineage
            hsa04658(916)  Th1 and Th2 cell differentiation
            hsa04659(916)  Th17 cell differentiation
            hsa04660(916)  T cell receptor signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Metabotropic glutamate receptor family
               Orphan GPRC5
                GPRC5D
                 D12724  Forimtamig (USAN/INN)
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                CD3E
                 D12724  Forimtamig (USAN/INN)
DBLINKS     CAS: 2649379-96-2
///
